BRIEF

on INNATE PHARMA (EPA:IPH)

Innate Pharma to Provide Financial Insights in Upcoming Conference Call

Stock price chart of INNATE PHARMA (EPA:IPH) showing fluctuations.

On September 10, 2026, Innate Pharma SA announced a scheduled conference call and webcast on September 17 to discuss the company's financial results for the first half of 2026. This event, aimed at updating stakeholders on the company's business, will feature key executives, including CEO Jonathan Dickinson and CFO Frédéric Lombard. It is set to start at 2:00 p.m. CEST/8:00 a.m. EDT.

The conference will be accessible through links provided on the Innate Pharma website. Furthermore, a replay of the webcast will be available for 90 days post-event. The call serves as an opportunity for investors and interested parties to gain insights into Innate Pharma's recent developments and strategic direction.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all INNATE PHARMA news